{"id":"https://openalex.org/W2805987317","doi":"https://doi.org/10.1038/s41525-018-0055-6","title":"Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin","display_name":"Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin","publication_year":2018,"publication_date":"2018-06-07","ids":{"openalex":"https://openalex.org/W2805987317","doi":"https://doi.org/10.1038/s41525-018-0055-6","mag":"2805987317","pmid":"https://pubmed.ncbi.nlm.nih.gov/29951225","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6010465"},"language":"en","primary_location":{"id":"doi:10.1038/s41525-018-0055-6","doi":"https://doi.org/10.1038/s41525-018-0055-6","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41525-018-0055-6","pdf_url":"https://www.nature.com/articles/s41525-018-0055-6.pdf","source":{"id":"https://openalex.org/S2737523697","display_name":"npj Genomic Medicine","issn_l":"2056-7944","issn":["2056-7944"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Genomic Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41525-018-0055-6.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088111017","display_name":"Pedro Torres\u2010Ayuso","orcid":"https://orcid.org/0000-0003-2213-9014","observed_orcids":["https://orcid.org/0000-0003-2213-9014"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Pedro Torres-Ayuso","raw_affiliation_strings":["1Signalling Networks in Cancer Group, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","2Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 USA","Signalling Networks in Cancer Group, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK"],"raw_orcid":"https://orcid.org/0000-0003-2213-9014","affiliations":[{"raw_affiliation_string":"1Signalling Networks in Cancer Group, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"2Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Signalling Networks in Cancer Group, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102952340","display_name":"Sudhakar Sahoo","orcid":"https://orcid.org/0009-0002-8491-5031","observed_orcids":["https://orcid.org/0009-0002-8491-5031","https://orcid.org/0000-0003-3689-8230"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sudhakar Sahoo","raw_affiliation_strings":["3Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112904658","display_name":"Garry Ashton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Garry Ashton","raw_affiliation_strings":["4Histology, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","Histology, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Histology, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Histology, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070368343","display_name":"Elvira An","orcid":"https://orcid.org/0000-0001-8024-7975","observed_orcids":["https://orcid.org/0000-0001-8024-7975"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elvira An","raw_affiliation_strings":["2Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 USA","Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044564918","display_name":"Nicole Simms","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Nicole Simms","raw_affiliation_strings":["5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","Clinical and Experimental Pharmacology Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112905357","display_name":"Melanie Galvin","orcid":"https://orcid.org/0000-0002-2002-5251","observed_orcids":["https://orcid.org/0000-0002-2002-5251"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Melanie Galvin","raw_affiliation_strings":["5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","Clinical and Experimental Pharmacology Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019089933","display_name":"Hui Sun Leong","orcid":"https://orcid.org/0000-0003-0890-6432","observed_orcids":["https://orcid.org/0000-0003-0890-6432"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hui Sun Leong","raw_affiliation_strings":["3Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033719663","display_name":"Kristopher K. Frese","orcid":"https://orcid.org/0000-0002-1369-0907","observed_orcids":["https://orcid.org/0000-0002-1369-0907"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kristopher K Frese","raw_affiliation_strings":["5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","Clinical and Experimental Pharmacology Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070472807","display_name":"Kathryn Simpson","orcid":"https://orcid.org/0000-0002-4386-0401","observed_orcids":["https://orcid.org/0000-0002-4386-0401"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kathryn Simpson","raw_affiliation_strings":["5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","Clinical and Experimental Pharmacology Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070242435","display_name":"Natalie Cook","orcid":"https://orcid.org/0000-0003-2606-1082","observed_orcids":["https://orcid.org/0000-0003-2606-1082"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Natalie Cook","raw_affiliation_strings":["6Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX UK","Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK"],"raw_orcid":"https://orcid.org/0000-0003-2606-1082","affiliations":[{"raw_affiliation_string":"6Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]},{"raw_affiliation_string":"Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049602345","display_name":"Andrew M. Hughes","orcid":"https://orcid.org/0000-0002-8690-4056","observed_orcids":["https://orcid.org/0000-0002-8690-4056"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew Hughes","raw_affiliation_strings":["6Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX UK","Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]},{"raw_affiliation_string":"Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072265839","display_name":"Crispin\u00a0J. Miller","orcid":"https://orcid.org/0000-0003-4341-1283","observed_orcids":["https://orcid.org/0000-0003-4341-1283","https://orcid.org/0000-0002-2649-6695"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Crispin J Miller","raw_affiliation_strings":["3Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Computational Biology Support Team, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059637661","display_name":"Richard Marais","orcid":"https://orcid.org/0000-0001-7484-4183","observed_orcids":["https://orcid.org/0000-0001-7484-4183"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4392738304","display_name":"Cancer Research UK Manchester Centre","ror":"https://ror.org/033svsm10","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210133995","https://openalex.org/I4392738304"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Marais","raw_affiliation_strings":["7Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","8Cancer Research UK Manchester Experimental Cancer Medicines Centre, The University of Manchester, Manchester, M20 4BX UK","Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"8Cancer Research UK Manchester Experimental Cancer Medicines Centre, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4392738304"]},{"raw_affiliation_string":"Molecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039337111","display_name":"Caroline Dive","orcid":"https://orcid.org/0000-0002-1726-8850","observed_orcids":["https://orcid.org/0000-0002-1726-8850"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4392738304","display_name":"Cancer Research UK Manchester Centre","ror":"https://ror.org/033svsm10","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210133995","https://openalex.org/I4392738304"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Caroline Dive","raw_affiliation_strings":["5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","8Cancer Research UK Manchester Experimental Cancer Medicines Centre, The University of Manchester, Manchester, M20 4BX UK","Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","Clinical and Experimental Pharmacology Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Clinical and Experimental Pharmacology Group; Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"8Cancer Research UK Manchester Experimental Cancer Medicines Centre, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4392738304"]},{"raw_affiliation_string":"Cancer Research UK Manchester Institute, The University of Manchester, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"Clinical and Experimental Pharmacology Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080991347","display_name":"Matthew Krebs","orcid":"https://orcid.org/0000-0001-7540-3064","observed_orcids":["https://orcid.org/0000-0001-7540-3064"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4392738304","display_name":"Cancer Research UK Manchester Centre","ror":"https://ror.org/033svsm10","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210133995","https://openalex.org/I4392738304"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Matthew G Krebs","raw_affiliation_strings":["6Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX UK","8Cancer Research UK Manchester Experimental Cancer Medicines Centre, The University of Manchester, Manchester, M20 4BX UK","Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]},{"raw_affiliation_string":"8Cancer Research UK Manchester Experimental Cancer Medicines Centre, The University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4392738304"]},{"raw_affiliation_string":"Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester and Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, M20 4BX, UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210133995"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061354302","display_name":"John Brognard","orcid":"https://orcid.org/0000-0002-9243-6615","observed_orcids":["https://orcid.org/0000-0002-9243-6615"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210129527","display_name":"Cancer Research UK Manchester Institute","ror":"https://ror.org/037405c78","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801316944","https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210149717","display_name":"Center for Cancer Research","ror":"https://ror.org/05bjen692","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"John Brognard","raw_affiliation_strings":["1Signalling Networks in Cancer Group, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","2Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 USA","Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Signalling Networks in Cancer Group, Cancer Research UK, Manchester Institute, University of Manchester, Manchester, M20 4BX UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527"]},{"raw_affiliation_string":"2Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]},{"raw_affiliation_string":"Signaling Networks in Cancer Section, Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884","https://openalex.org/I4210149717"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5061354302","https://openalex.org/A5080991347"],"corresponding_institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210129527","https://openalex.org/I4210130649","https://openalex.org/I4210133995","https://openalex.org/I4210140884","https://openalex.org/I4210149717","https://openalex.org/I4392738304"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":0.5948,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.55946926,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"3","issue":"1","first_page":"15","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12379","display_name":"Cancer Diagnosis and Treatment","score":0.06520000100135803,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.05429999902844429,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-of-unknown-primary","display_name":"cancer of unknown primary","score":0.9200000166893005},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/actionable-therapeutic-targets","display_name":"actionable targets","score":0.7059999704360962},{"id":"https://openalex.org/keywords/signaling-pathway-analysis","display_name":"signaling pathway analysis","score":0.7900000214576721},{"id":"https://openalex.org/keywords/pik3ca-amplification","display_name":"PIK3CA amplification","score":0.9229999780654907},{"id":"https://openalex.org/keywords/rictor","display_name":"Rictor","score":0.906000018119812},{"id":"https://openalex.org/keywords/azd5363","display_name":"AZD5363","score":0.8600000143051147},{"id":"https://openalex.org/keywords/akt-inhibitors","display_name":"AKT inhibitors","score":0.7570000290870667},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9829999804496765},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.5699999928474426},{"id":"https://openalex.org/keywords/rare-tumor","display_name":"rare tumor","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.587847888469696},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5392493009567261},{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.49946093559265137},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4644380211830139},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44694727659225464},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4327089190483093},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4305083155632019},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.4271519184112549},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.38534167408943176},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.37257498502731323},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37028878927230835},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.35325759649276733},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.30312106013298035},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2476184070110321}],"mesh":[],"locations_count":8,"locations":[{"id":"doi:10.1038/s41525-018-0055-6","doi":"https://doi.org/10.1038/s41525-018-0055-6","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41525-018-0055-6","pdf_url":"https://www.nature.com/articles/s41525-018-0055-6.pdf","source":{"id":"https://openalex.org/S2737523697","display_name":"npj Genomic Medicine","issn_l":"2056-7944","issn":["2056-7944"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Genomic Medicine","raw_type":"journal-article"},{"id":"doi:10.1101/254342","doi":"https://doi.org/10.1101/254342","is_oa":true,"landing_page_url":"https://doi.org/10.1101/254342","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2018/01/26/254342.1.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmh:oai:europepmc.org:4969148","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6010465","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6010465","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6010465","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ Genom Med","raw_type":"Text"},{"id":"pmid:29951225","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29951225","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"NPJ genomic medicine","raw_type":"Case Reports"},{"id":"pmh:oai:pure.atira.dk:openaire/f46d854e-2acd-49b6-a0c2-712dac1f085e","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/f46d854e-2acd-49b6-a0c2-712dac1f085e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Torres-ayuso, P, Sahoo, S, Ashton, G, An, E, Simms, N, Galvin, M, Leong, H S, Frese, K K, Simpson, K, Cook, N, Hughes, A, Miller, C J, Marais, R, Dive, C, Krebs, M G & Brognard, J 2018, 'Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin', Genomic Medicine, vol. 3, no. 1, 15. https://doi.org/10.1038/s41525-018-0055-6","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.gla.ac.uk:214584","doi":null,"is_oa":true,"landing_page_url":"http://eprints.gla.ac.uk/214584/1/214584.pdf","pdf_url":"http://eprints.gla.ac.uk/214584/1/214584.pdf","source":{"id":"https://openalex.org/S4210235606","display_name":"ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)","issn_l":"2622-8912","issn":["2622-8912","2622-8920"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/I4405259220","host_organization_name":"Institut Agama Islam Negeri Langsa","host_organization_lineage":["https://openalex.org/I4405259220"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Articles"},{"id":"pmh:oai:doaj.org/article:6743f199e70e4f5c897275f2924da090","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/6743f199e70e4f5c897275f2924da090","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"npj Genomic Medicine, Vol 3, Iss 1, Pp 1-7 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41525-018-0055-6","doi":"https://doi.org/10.1038/s41525-018-0055-6","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41525-018-0055-6","pdf_url":"https://www.nature.com/articles/s41525-018-0055-6.pdf","source":{"id":"https://openalex.org/S2737523697","display_name":"npj Genomic Medicine","issn_l":"2056-7944","issn":["2056-7944"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"npj Genomic Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[{"id":"https://openalex.org/G1626027501","display_name":null,"funder_award_id":"(C5759/A20971","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G2222578041","display_name":null,"funder_award_id":"19278","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G2309850972","display_name":null,"funder_award_id":"C147/A18083","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G2797483627","display_name":null,"funder_award_id":"A20971","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G3042422118","display_name":null,"funder_award_id":"AZD5363","funder_id":"https://openalex.org/F4320307770","funder_display_name":"AstraZeneca"},{"id":"https://openalex.org/G4731684068","display_name":null,"funder_award_id":"C5759","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G5194450556","display_name":null,"funder_award_id":"17240","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7400414912","display_name":null,"funder_award_id":"19279","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G7943889125","display_name":null,"funder_award_id":"15675","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8175362151","display_name":null,"funder_award_id":"20465","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G8286353319","display_name":null,"funder_award_id":"C5759","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G832828744","display_name":null,"funder_award_id":"22902","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G9000893983","display_name":"Oncogenic Kinases in Cancer","funder_award_id":"ZIABC011691","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320309412","display_name":"Lung Cancer Research Foundation","ror":"https://ror.org/00f7y2s26"},{"id":"https://openalex.org/F4320310214","display_name":"Fundaci\u00f3n Ram\u00f3n Areces","ror":"https://ror.org/04ra91131"},{"id":"https://openalex.org/F4320314451","display_name":"Christie Charity","ror":null},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2805987317.pdf","grobid_xml":"https://content.openalex.org/works/W2805987317.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1940682904","https://openalex.org/W1984068087","https://openalex.org/W2059790366","https://openalex.org/W2088293861","https://openalex.org/W2088942535","https://openalex.org/W2103441770","https://openalex.org/W2108234281","https://openalex.org/W2117497402","https://openalex.org/W2119180969","https://openalex.org/W2126298009","https://openalex.org/W2126783165","https://openalex.org/W2127063807","https://openalex.org/W2157983986","https://openalex.org/W2168133698","https://openalex.org/W2194439446","https://openalex.org/W2238537990","https://openalex.org/W2258535515","https://openalex.org/W2273553573","https://openalex.org/W2438829874","https://openalex.org/W2555633665","https://openalex.org/W2578120387","https://openalex.org/W2601520864","https://openalex.org/W2611387862","https://openalex.org/W2700576167","https://openalex.org/W2751210758"],"related_works":["https://openalex.org/W2788931130","https://openalex.org/W2887365246","https://openalex.org/W4226128625","https://openalex.org/W2885290888","https://openalex.org/W2049561215","https://openalex.org/W2603622087","https://openalex.org/W2545651338","https://openalex.org/W3083540289","https://openalex.org/W3179931814","https://openalex.org/W2462006858"],"abstract_inverted_index":{"Abstract":[0],"Precision":[1],"medicine":[2],"aims":[3],"to":[4,8,30,83,160],"tailor":[5],"cancer":[6],"therapies":[7,180],"target":[9],"specific":[10],"tumorpromoting":[11],"aberrations.":[12],"For":[13],"tumors":[14],"that":[15,116,192],"lack":[16],"actionable":[17,85,91,205],"drivers,":[18],"extensive":[19],"molecular":[20],"characterization":[21],"and":[22,45,76,112,120,145,156,158,170,207],"pre-clinical":[23],"drug":[24,77],"efficacy":[25,78,142],"studies":[26],"will":[27,208],"be":[28],"required":[29],"match":[31],"patients":[32],"with":[33,60,125],"the":[34,100,110,118,135,151,161,174,183],"appropriate":[35],"targeted":[36,179],"therapy.":[37],"A":[38],"cell":[39,154],"line":[40],"maintained":[41],"at":[42],"low":[43],"passage":[44],"a":[46,54,58,61],"patient-derived":[47],"xenograft":[48],"model":[49],"(PDX)":[50],"were":[51,80,93,148],"generated":[52],"using":[53],"fresh":[55],"biopsy":[56],"from":[57,178],"patient":[59,175,211],"poorly-differentiated":[62],"neuroendocrine":[63],"tumor":[64,152],"of":[65,99,109,127,134,143,204],"unknown":[66],"primary":[67],"origin.":[68],"Next-generation":[69],"sequencing,":[70],"high":[71,193],"throughput":[72,194],"signaling":[73,195],"network":[74],"analysis,":[75,141],"trials":[79],"then":[81],"conducted":[82],"identify":[84],"targets":[86],"for":[87,202],"therapeutic":[88],"intervention.":[89],"No":[90],"mutations":[92],"identified":[94],"after":[95],"whole":[96,104],"exome":[97],"sequencing":[98,106,200],"patient\u2019s":[101],"DNA;":[102],"however,":[103],"genome":[105],"revealed":[107,132],"amplification":[108,126],"3q":[111],"5p":[113],"chromosomal":[114],"arms,":[115],"include":[117],"PIK3CA":[119,144],"RICTOR":[121],"genes,":[122,129],"respectively.":[123],"Consistent":[124],"these":[128],"pathway":[130,196],"analysis":[131,197],"activation":[133],"AKT":[136,146,162],"pathway.":[137],"Based":[138],"on":[139],"this":[140],"inhibitors":[147],"evaluated":[149],"in":[150,168,171,210],"biopsy-derived":[153],"culture":[155],"PDX,":[157],"response":[159],"inhibitor":[163],"AZD5363":[164],"was":[165],"observed":[166],"both":[167],"vitro":[169],"vivo":[172],"indicating":[173],"would":[176],"benefit":[177],"directed":[181],"against":[182],"serine/threonine":[184],"kinase":[185],"AKT.":[186],"In":[187],"conclusion,":[188],"our":[189],"study":[190],"demonstrates":[191],"complements":[198],"next-generation":[199],"approaches":[201],"detection":[203],"alterations":[206],"aid":[209],"stratification":[212],"into":[213],"early-phase":[214],"clinical":[215],"trials.":[216]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2018-06-13T00:00:00"}